MeSH tree: C14.907.137.126.339
In a new study of more than 40,000 patients, researchers at Intermountain Health in Salt Lake City have found that patients who have no evidence of calcium in their coronary arteries are not only significantly less likely ...
Nov 8, 2025
0
121
Nearly 20 million people die every year from cardiovascular diseases, the leading cause of death worldwide. Genetic and environmental factors influence a person's risk of disease and severity, but microbes likely also play ...
Nov 6, 2025
0
22
In the treatment of larger narrowed blood vessels, drug-coated balloon catheters have been shown to deliver lasting and effective outcomes. Their minimally invasive nature makes them a viable alternative to stents. These ...
Nov 5, 2025
0
20
Female individuals may experience a three-fold reduction in mortality risk from coronary heart disease when following recommended exercise guidelines, compared to male individuals. These findings, published in Nature Cardiovascular ...
Oct 28, 2025
0
50
New study results from a large international all-comer population of percutaneous coronary intervention (PCI) candidates found that utilizing a strategy of sirolimus-eluting balloons with bailout stenting only if necessary ...
Oct 28, 2025
0
12
A comprehensive study of electronic health records for 57 million people living in England has revealed the evolving burden of cardiovascular diseases before, during and after the COVID-19 pandemic.
Oct 27, 2025
0
18
The strong opioid painkiller tramadol is not significantly effective at easing the chronic pain for which it's widely prescribed, finds a pooled data analysis of the available research, published in BMJ Evidence-Based Medicine.
Oct 7, 2025
0
113
Patients undergoing coronary angiography often experience anxiety both before and during the procedure, often treated by the administration of anti-anxiety medications. A new analysis being presented at the American College ...
Oct 2, 2025
0
13
Consumers read common supplement label phrases as promises of disease prevention or treatment, according to University of Texas Southwestern Medical Center and Duke University Medical Center research.
Researchers led by the National Heart, Lung, and Blood Institute report that menopausal hormone therapy relieved vasomotor symptoms without raising cardiovascular risk in younger women, but increased risk was evident in women ...
